Acepodia (6976.TWO) has a profit margin of -431519.93%, below the Healthcare sector average of 10.58%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Acepodia (6976.TWO) currently reports a profit margin of -431519.93% as of June 2026. That compares with -14737.97% in the prior-year period — down 2827.9% year over year. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore Acepodia's profit margin history and peer comparisons.
Acepodia's profit margin decreased from -14737.97% to -431519.93% — a 2827.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Acepodia's profit margin of -431519.93% is lower than the Healthcare sector average of 10.58%. That is roughly 4078557.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Acepodia's current -431519.93% should be judged against Healthcare norms (sector average: 10.58%) and against 6976.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -431519.93%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Acepodia, and consider following 6976.TWO for alerts when major investors trade the stock.